A GLOBAL AI-DRIVEN CODE LIST GENERATION TOOL WITH INTEGRATED JAPANESE MEDICAL DICTIONARY FOR SCALABLE CROSS-COUNTRY REAL-WORLD EVIDENCE
Author(s)
Luis Vaz, PhD1, Dessislava Veltcheva, PhD1, Bruno Casaes Teixeira, MSc, PharmD2.
1BMS, London, United Kingdom, 2Bristol Myers Squibb, Maidenhead, United Kingdom.
1BMS, London, United Kingdom, 2Bristol Myers Squibb, Maidenhead, United Kingdom.
OBJECTIVES: Cross-country inconsistencies reduce comparability, and manual creation limits codelist scalability and reproducibility. Japan presents a particularly acute challenge: no Japanese OMOP vocabulary exists, and six distinct terminology systems (disease receipt codes mapped to ICD-10, YJ drug codes, medical and dental procedure Kubun codes, and JLAC laboratory codes) are maintained by separate authorities with different update frequencies. We aimed to develop an AI-driven code list generation tool supported by a unified Japanese medical dictionary to enable governed, reproducible, and cross-country code list development.
METHODS: The AI Code List Generation Tool was developed across four stages: (1) harvesting and structuring existing validated study code lists into a searchable, metadata-tagged repository; (2) generating reproducible code lists using hierarchical dictionary expansion, rule-based inclusion/exclusion logic, and version-controlled audit trails; (3) building an AI agent architecture combining natural language understanding with a knowledge layer spanning internal code list repositories, medical dictionaries, and published literature; and (4) aligning with OHDSI Athena vocabularies for cross-market semantic translation. To address Japan-specific requirements, JADE (Japanese Analytical Dictionary for Evidence) was developed as an upstream contributor, systematically harmonising Japanese disease, drug and medical/dental procedures with lab codes, enriched with AI-assisted Japanese-to-English translation and longitudinal version tracking.
RESULTS: The disease dictionary component of JADE was delivered, unifying 27,687 unique disease codes across 47 versions with 24 unique columns and 10 documented schema changes. Drug codes and medical/dental procedure dictionaries are currently in development. The code list tool prototype, integrating JADE, UK, and US dictionaries, is targeting completion by mid-2026.
CONCLUSIONS: Combining an AI-driven code list generation tool with a harmonised Japanese medical dictionary addresses critical gaps in reproducibility, scalability, and cross-country comparability of RWD code lists, while establishing governed infrastructure for future AI-enabled real-world evidence generation.
METHODS: The AI Code List Generation Tool was developed across four stages: (1) harvesting and structuring existing validated study code lists into a searchable, metadata-tagged repository; (2) generating reproducible code lists using hierarchical dictionary expansion, rule-based inclusion/exclusion logic, and version-controlled audit trails; (3) building an AI agent architecture combining natural language understanding with a knowledge layer spanning internal code list repositories, medical dictionaries, and published literature; and (4) aligning with OHDSI Athena vocabularies for cross-market semantic translation. To address Japan-specific requirements, JADE (Japanese Analytical Dictionary for Evidence) was developed as an upstream contributor, systematically harmonising Japanese disease, drug and medical/dental procedures with lab codes, enriched with AI-assisted Japanese-to-English translation and longitudinal version tracking.
RESULTS: The disease dictionary component of JADE was delivered, unifying 27,687 unique disease codes across 47 versions with 24 unique columns and 10 documented schema changes. Drug codes and medical/dental procedure dictionaries are currently in development. The code list tool prototype, integrating JADE, UK, and US dictionaries, is targeting completion by mid-2026.
CONCLUSIONS: Combining an AI-driven code list generation tool with a harmonised Japanese medical dictionary addresses critical gaps in reproducibility, scalability, and cross-country comparability of RWD code lists, while establishing governed infrastructure for future AI-enabled real-world evidence generation.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
RWD38
Topic
Health Service Delivery & Process of Care, Real World Data & Information Systems, Study Approaches
Topic Subcategory
Reproducibility & Replicability
Disease
No Additional Disease & Conditions/Specialized Treatment Areas